Sridar Iyengar - Dr Reddys Non-Executive Independent Director

RDY -- USA Stock  

USD 38.01  0.07  0.18%

Mr. Sridar A. Iyengar serves as NonExecutive Independent Director of Dr. Reddy Laboratories Ltd. Mr. Sridar Iyengar is an independent mentor investor in early stage start ups and companies. Earlier, he was a senior partner with KPMG in the US and UK and also served as the Chairman CEO of KPMGs operations in India. For more than 35 years, he has worked with a large number of companies, advising them on strategy and other issues
Age: 70  Director Since 2011  Ph.D    
91 40 4900 2900
Iyengar holds directorship in Mahindra Holidays and Resorts India Limited, ICICI Venture Funds Management Company Limited, Cleartrip Private Limited in India; AverQ Inc. in the US; Cleartrip Inc. in Cayman Islands; Holiday Club Resorts OY in Finland and our whollyowned subsidiary, Dr. Reddy?s Laboratories S.A., in Switzerland. He holds a Bachelor of Commerce degree from Calcutta University, India and is a Fellow of the Institute of Chartered Accountants in England and Wales.

Management Efficiency

The company has Return on Asset of 5.42 % which means that on every $100 spent on asset it made $5.42 of profit. This is considered to be average in the sector. In the same way, it shows return on shareholders equity (ROE) of 15.08 % implying that it generated $15.08 on every 100 dollars invested.
The company has 811.73M in debt with debt to equity (D/E) ratio of 23.5 . This implies that the company may be unable to create cash to meet all of its financial commitments. Dr Reddys Laboratories has Current Ratio of 1.85 which is typical for the industry and considered as normal.

Similar Executives

Showing few of many executives


Linda RhodesZoetis
William SteereZoetis
Alan GarberVertex Pharmaceuticals Incorpor
Huda ZoghbiRegeneron Pharmaceuticals
Sangeeta BhatiaVertex Pharmaceuticals Incorpor
Jeffrey SmithPerrigo Company plc
Christine PoonRegeneron Pharmaceuticals
Joseph GoldsteinRegeneron Pharmaceuticals
Gary CohenPerrigo Company plc
Robert ScullyZoetis
Herman MorrisPerrigo Company plc
Elaine UllianVertex Pharmaceuticals Incorpor
Shlomo YanaiPerrigo Company plc
Margaret McGlynnVertex Pharmaceuticals Incorpor
Sanjay KhoslaZoetis
Marc TessierLavigneRegeneron Pharmaceuticals
Donal OConnorPerrigo Company plc
Ellen HoffingPerrigo Company plc
Louise ParentZoetis
Terrence KearneyVertex Pharmaceuticals Incorpor
Larry CordellOrigin Agritech Limited

Entity Summary

Reddys Laboratories Limited operates as an integrated pharmaceutical company worldwide. Reddys Laboratories Limited was founded in 1984 and is headquartered in Hyderabad, India. Dr Reddys operates under Drug Manufacturers - Specialty Generic classification in USA and is traded on BATS Exchange. It employs 21966 people.Dr Reddys Laboratories Ltd (RDY) is traded on BATS Exchange in USA and employs 21,966 people.

Dr Reddys Laboratories Leadership Team

G Prasad, Co-Chairman of the Board, Chief Executive Officer, Managing Director
MARC KIKUCHI, Chief Executive Officer, North America Generics
Hans Hasler, Additional Independent Director
Leo Puri, Non-Executive Independent Director
Sandeep Poddar, Compliance Officer, Company Secretary
Satish Reddy, Co-Chairman of the Board
Kedar Upadhye, IR Contact Officer
Samiran Das, Executive Vice President Head - FTO and GGPM
Sauri Gudlavalleti, Global Head of Integrated Product Development Organization
YUGANDHAR PUVVALA, Global Head of Supply Chain
Amit Biswas, Executive Vice President - Integrated Product Development
Ravi Bhoothalingam, Non-Executive Independent Director
Alok Sonig, Senior Vice President & India Business Head (Generics)
Allan Oberman, Non-Executive Independent Director
J Ramachandran, Executive Vice President-Management Systems and Corporate Initiatives
Prasad Menon, Lead Non-Executive Independent Director
K Rao, Sr. Vice President & Head ? Chemical Technical Operations (CTO)
Abhijit Mukherjee, COO
Anil Namboodiripad, Global Head of Proprietary Products
Saumen Chakraborty, President, Chief Financial Officer and Global Head of ITBPE, Legal & Compliance and FMCRE
SANJAY SHARMA, Global Head of Manufacturing
Shikha Sharma, Non-Executive Independent Director
Sridar Iyengar, Non-Executive Independent Director
Ganadhish Kamat, Executive Vice President and Global Head-Quality
Sripada Chandrasekhar, President, Global Head of HR and Member of Management Council
Omkar Goswami, Non-Executive Independent Director
Erez Israeli, Chief Operating Officer and Global Head of Generics & PSAI
Kalpana Morparia, Non-Executive Independent Director
Bharat Doshi, Non-Executive Independent Director
J Moreau, Non-Executive Independent Director
Raymond Vre, Global Head of Biologics
Raghav Chari, Senior Vice President - Proprietary Products
Bruce Carter, Non-Executive Independent Director
Saunak Savla, IR Contact Officer
Ashok Ganguly, Non-Executive Independent Director
Umang Vohra, Executive Vice President Head - North America Generics
M Ramana, Chief Executive Officer, Branded Markets (India and Emerging Markets)
Cartikeya Reddy, Senior Vice President Head - Biologics
Anupam Puri, Non-Executive Independent Director
Archana Bhaskar, Chief Human Resource Officer
Deepak Sapra, Global Head of PSAI

Stock Performance Indicators

Did you try this?

Run Chance of Distress Now


Chance of Distress

Get analysis of equity chance of financial distress in the next 2 years
All  Next Launch Module

Currently Active Assets on Macroaxis

Purchased few shares of
few hours ago
Traded for 188.14
Purchased a lot of shares of
few hours ago
Traded for 150.35
Purchased few shares of
few hours ago
Traded for 175.29
Purchased a lot of shares of
few hours ago
Traded for 152.77
Purchased over 300 shares of
few hours ago
Traded for 9.25
Additionally take a look at Your Equity Center. Please also try Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.